Seq #243 Friday, 11 March 2005

2:00 PM-4:00 PM Baltimore Convention Center Exhibit Hall E-F, Poster
Streptococcus mutans
 
2202  Epitope Immunogenicity in Putative Functional Domains of S. mutans GbpB
C.E. SMITH1, W.F. KING2, M.A. TAUBMAN2, and D.J. SMITH2, 1Forsyth Institute, Harvard School of Dental Medicine, Boston, MA, USA, 2Forsyth Institute, Bostoon, MA, USA
2203  Detection of Differential Gene Expression of Streptococcus mutans Using RFDD-PCR
Z. HUANG, Shanghai Second Medical University, 9th Affliated Hospital, China, and Z. LIU, Shanghai Second Medical University, China
2204  Contribution of Streptococcus mutans PAc to Bacteremia Occurrence
K. NAKANO, R. NOMURA, M. TSUJI, K. FUJITA, K. NISHIMURA, and T. OOSHIMA, Osaka University, Japan
2205  WITHDRAWN
2206  Gene expression and enzyme activity of Streptococcus mutans Lactate dehydrogenase
D.Q. YANG1, T.J. LIU2, H. ZHUANG2, S. LI2, and J.B. YANG2, 1Sichuan University, West China College of Stomatology, Chengdu, China, 2Sichuan University, Chengdu, China
2207  Persistence of Mutans Streptococci in Nasopharyngeal Carcinoma Patients after Radiotherapy
Z. BIAN, L.Y. MENG, J.R. LIU, M.W. FAN, M. NIE, Z. CHEN, B. PENG, and Y. GAN, Wuhan University, China
2208  The A-region/P-region interaction contributes to Streptococcus mutans P1 surface expression
T.B. SEIFERT1, A.S. BLEIWEIS2, W.P. MCARTHUR2, and L.J. BRADY2, 1University of Florida, Department of Oral Biology, Gainesville, USA, 2University of Florida, Gainesville, USA
2209  Streptococcus mutans P1 sequences that Contribute to a complex epitope
R. ROBINETTE, W.P. MCARTHUR, and L.J. BRADY, University of Florida, Gainesville, USA
2210  Construction of Reporter Vectors for Gene Regulation Studies in S.mutans
T. NGUYEN, P. TSANG, J. KRETH, J. MERRITT, W. SHI, and F. QI, UCLA School of Dentistry, Los Angeles, CA, USA
2211  Microbial Cell-Cell Interactions and Virulence Regulation by Streptococcus mutans
D.M. YATES1, Z.T. WEN1, and R.A. BURNE2, 1University of Florida, Gainesvillle, USA, 2University of Florida, Gainesville, USA
2212  Characterization of mutacin IV (nlmA) expression of Streptococcus mutans
A.A. RASTEGAR, J. KRETH, F. QI, and W. SHI, UCLA School of Dentistry, Los Angeles, CA, USA
2213  Analogs of the Streptococcus mutans CSP as Inhibitors of Quorum-Sensing
Y.-C.C. HUANG, C. LEVESQUE, and D.G. CVITKOVITCH, University of Toronto, Canada
2214  Application to Serotyping of Streptococcus mutans by Pulsed-Field Gel Electrophoresis
R. MINEYAMA, Nippon Dental University, School of Dentistry at Niigata, Niigata, Japan, and S. YOSHINO, Nippon Dental University, Niigata, Japan
2215  ComC –dependent antimicrobial sensitivity of Streptococcus mutans GS5
M. NAKANO, State University of New York - Buffalo, USA, and H.K. KURAMITSU, State University of New York - Buffalo, USA
2216  Proteome Analysis of LuxS-Mediated Signaling Pathways in Streptococcus mutans
L. ZHU, M. SONDEJ, J. MERRITT, J. KRETH, W. SHI, and F. QI, UCLA School of Dentistry, Los Angeles, CA, USA
2217  Effects of Dental Plaque Control Agents on Streptococcus sanguis Biofilm
R. MA1, Z. TANG2, M. ZHU3, and Z. LIU1, 1Shanghai Ninth People's Hospital, China, 2ShangHai Ninth People's Hospital, Shanghai Second Medical University, Shanghai, China, 3University of Illinois College of Dentistry, Chicago, USA
2218  WITHDRAWN
2219  Screening of alternative sources of transmission of Streptococcus mutans genotypes
A.C. ALVES, R.D. NOGUEIRA, J.F. HÖFLING, and R.O. MATTOS-GRANER, Piracicaba School of Dentistry, State University of Campinas, Brazil, Brazil
2220  Effects of SspB-peptide for attachment of Streptococcus mutans to s-HA
K. OKUDA1, M. KUMADA2, S. TAMURA2, N. HANADA3, and H. SENPUKU4, 1Kyushu University, Fukuoka, Japan, 2Tokyo Medical & Dental University, Japan, 3National Institute of Public Health, Tokyo, Japan, 4National Institute of Infectious Diseases, Tokyo, Japan
2221  Biological effects of lactic acid bacteria to Streptococcus mutans biofilm
M. KUMADA1, S. TAMURA1, M. KAWATA2, H. YAMAMURA2, J. TAGAMI3, and H. SENPUKU4, 1Tokyo Medical & Dental University, Japan, 2Biofermin Pharmaceutical Co., Ltd, hyougo, Japan, 3Tokyo Medical & Dental University, COE Program,FRMDRTB at TMDU, Japan, 4National Institute of Infectious Diseases, Tokyo, Japan
2222  T-cells response, IgA and IgG to Streptococcus mutans PAc(365-377) peptide
N.S. ROA, S.I. GOMEZ, and A. RODRIGUEZ, Pontificia Universidad Javeriana, Bogota, Colombia

Back to the: Microbiology / Immunology and Infection Control Program

Back to the IADR/AADR/CADR 83rd General Session (March 9-12, 2005)

Top Level Search